Dianthus Therapeutics | Los Gastos De Explotación



Operating Expenses Cambio Fecha
Adcock Ingram Holdings ZAR 4.23B 196.72M 2024-12
Alaunos Therapeutics USD 759K 391K 2024-12
Avita Medical AUD 28.36M 2.44M 2024-12
Celltrion KRW 718.99B 24.68B 2025-06
Cspc Pharmaceutical CNY 5.22B 248.9M 2025-03
Dianthus Therapeutics USD 35.12M 1.88M 2025-06
Divis Laboratories Ltd 17.93B 130M 2025-06
IQVIA Holdings USD 3.46B 124M 2025-06
Kangmei Pharma CNY 1.25B 35.75M 2025-06
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 132.33M 179.02M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 19.8M 9.46M 2024-12
Moderna USD 1.04B 113M 2025-06
Neuren Pharmaceuticals AUD 17.41M 2.86M 2024-12
Organigram Holdings CAD 72.9M 18.86M 2025-06
Organon & Co USD 1.27B 144M 2025-06
Pharma Mar EUR 32.29M 9.66M 2025-06
Qiagen NV USD 397.57M 39.27M 2025-06
Revvity USD 629.52M 36.99M 2025-06
Sartorius EUR 722.5M 23.1M 2025-06
Sino Biopharmaceutical CNY 11.66B 352.34M 2024-12
Tectonic Therapeutic USD 22.33M 8.34M 2025-06
Tilray USD 253.17M 16.55M 2024-11
Viatris USD 3.4B 2.88B 2025-06
Xeris Pharmaceuticals USD 67.06M 8.64M 2025-06
Zz Pientze Pharmaceu 1.68B 272.39M 2025-06


Dianthus Therapeutics Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Sep 2025.